Does Patient Compliance Influence Wearable Cardioverter Defibrillator Effectiveness? A Single-Center Experience

The study was designed to assess patient adherence wearable cardioverter defibrillator as an indicator of device effectiveness. training is not widely properly standardized. We enrolled 25 patients with a prevent sudden cardiac death between June 2020 and August 2022. Among them, 84% were male median age 63.6 years. indication ischemic (44%) non-ischemic (56%) disease. followed-up until the decision upgrade implantable taken. trained according our suggested protocol. wear time 90 days, daily 23.5 h, similar throughout sex, age, groups. In total, 24% participants underwent implantation. Between device-implanted non-implanted groups, left ventricular ejection fraction indexed end-diastolic volume significantly different (EF 35.8 ± 12 vs. 46.4 8.5%, p = 0.028, iEDV 108 52 70.7 21.1 mL/m2, 0.024). did find any differences in magnetic resonance data, even though all who implantation had late gadolinium enhancement spots. Our results support standardized obtain great instructions therefore its